Lesinurad/Allopurinol

雷西纳德/别嘌呤

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLesinurad/Allopurinol
Drug Alias Name来辛奴拉/别嘌呤Lesinurad and AllopurinolAllopurinol/LesinuradDuzallo
ClassificationSmall molecules
Mechanisms of ActionXanthine dehydrogenase inhibitorsUric acid transporter 1 inhibitorsSolute carrier family 22 member 11 inhibitors
TargetsUric acid transporter 1Xanthine dehydrogenaseSolute carrier family 22 member 11
Therapy Area/IndicationsHyperuricemiaGout
Global Approved IndicationsHyperuricemiaGout
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2017/08/18
Country/TerritoryUnited StatesEU
CombinationsYes AllopurinolLesinurad
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesIronwood Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGrunenthal GmbhArdea Biosciences IncIronwood Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHyperuricemiaGout

Other Information

ATC CodeM04AA51
Related LinksN/A